united states food and drug administration
- K
Biocon's Liraglutide Injection Gains USFDA Approval, Targeting Obesity Market
Biocon Secures US FDA Approval for Liraglutide Injection to Tap Growing GLP-1 Market Biocon Receives US FDA Nod for Complex Liraglutide Formulation Biocon Ltd announced on Tuesday that it has received approval from the US Food and Drug Administration for its complex formulation, Liraglutide...- Karthik
- Thread
- biocon ltd bse drug-device combination european union fda approval glp-1 receptor agonists glucagon-like peptide-1 liraglutide obesity treatment pharmaceutical formulation prefilled pens type 2 diabetes united states food and drug administration weight management
- Replies: 0
- Forum: Stocks